245 related articles for article (PubMed ID: 9052343)
1. Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators.
Stroobandt R; Stiels B; Hoebrechts R
Am J Cardiol; 1997 Feb; 79(4):418-23. PubMed ID: 9052343
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
Bellandi F; Simonetti I; Leoncini M; Frascarelli F; Giovannini T; Maioli M; Dabizzi RP
Am J Cardiol; 2001 Sep; 88(6):640-5. PubMed ID: 11564387
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.
Bianconi L; Mennuni M; Lukic V; Castro A; Chieffi M; Santini M
J Am Coll Cardiol; 1996 Sep; 28(3):700-6. PubMed ID: 8772759
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study.
Dogan A; Ergene O; Nazli C; Kinay O; Altinbas A; Ucarci Y; Ergene U; Ozaydin M; Gedikli O
Acta Cardiol; 2004 Jun; 59(3):255-61. PubMed ID: 15255456
[TBL] [Abstract][Full Text] [Related]
5. Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group.
Crijns HJ; Gosselink AT; Lie KI
Cardiovasc Drugs Ther; 1996 May; 10(2):145-52. PubMed ID: 8842506
[TBL] [Abstract][Full Text] [Related]
6. Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators.
Fresco C; Proclemer A; Pavan A; Buia G; Vicentini A; Pavan D; Morgera T
Clin Cardiol; 1996 May; 19(5):409-12. PubMed ID: 8723601
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological cardioversion of atrial fibrillation with intravenous and oral propafenone].
Peciuliene I; Lukoseviciūte A
Medicina (Kaunas); 2002; 38(12):1212-6. PubMed ID: 12552163
[TBL] [Abstract][Full Text] [Related]
8. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial.
Boriani G; Biffi M; Capucci A; Botto GL; Broffoni T; Rubino I; Della Casa S; Sanguinetti M; Magnani B
Ann Intern Med; 1997 Apr; 126(8):621-5. PubMed ID: 9103129
[TBL] [Abstract][Full Text] [Related]
9. Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study.
Capucci A; Villani GQ; Aschieri D; Piepoli M
Int J Cardiol; 1999 Feb; 68(2):187-96. PubMed ID: 10189007
[TBL] [Abstract][Full Text] [Related]
10. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of intravenous and per os propafenone in the ambulatory treatment of recent-onset atrial fibrillation].
Margheri M; Fradella G; Maioli M; Paterni M; Bartoli P; Bonechi F; Brandinelli A; Mazza F; Sansoni M; Zipoli A
G Ital Cardiol; 1992 Mar; 22(3):257-65. PubMed ID: 1426770
[TBL] [Abstract][Full Text] [Related]
12. Oral loading with propafenone: a placebo-controlled study in elderly and nonelderly patients with recent onset atrial fibrillation.
Boriani G; Biffi M; Capucci A; Botto GL; Broffoni T; Rubino I; Della Casa S; Sanguinetti M; Branzi A; Magnani B
Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2465-9. PubMed ID: 9825368
[TBL] [Abstract][Full Text] [Related]
13. Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study.
Bellandi F; Dabizzi RP; Cantini F; Natale MD; Niccoli L
Cardiovasc Drugs Ther; 1996 May; 10(2):153-7. PubMed ID: 8842507
[TBL] [Abstract][Full Text] [Related]
14. Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens.
Botto GL; Capucci A; Bonini W; Boriani G; Broffoni T; Barone P; Espureo M; Lombardi R; Molteni S; Ferrari G
Int J Cardiol; 1997 Jan; 58(1):55-61. PubMed ID: 9021428
[TBL] [Abstract][Full Text] [Related]
15. Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study.
Azpitarte J; Alvarez M; Baún O; García R; Moreno E; Martín F; Tercedor L; Fernández R
Eur Heart J; 1997 Oct; 18(10):1649-54. PubMed ID: 9347277
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm.
Martínez-Marcos FJ; García-Garmendia JL; Ortega-Carpio A; Fernández-Gómez JM; Santos JM; Camacho C
Am J Cardiol; 2000 Nov; 86(9):950-3. PubMed ID: 11053705
[TBL] [Abstract][Full Text] [Related]
17. Oral propafenone for rapid conversion of recent onset atrial fibrillation--a review.
Hughes C; Sunderji R; Gin K
Can J Cardiol; 1997 Sep; 13(9):839-42. PubMed ID: 9343033
[TBL] [Abstract][Full Text] [Related]
18. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
Frick M; Darpö B; Ostergren J; Rosenqvist M
Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
[TBL] [Abstract][Full Text] [Related]
19. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
[TBL] [Abstract][Full Text] [Related]
20. [Intravenous propafenone for conversion of atrial fibrillation in the emergency room].
Antonelli D; Freedberg NA; Feldman A; Darawsha A; Rosenfeld T
Harefuah; 2004 Jul; 143(7):471-4, 552, 551. PubMed ID: 15669418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
